| 产品编号 | CFN70141 | |
| CAS编号 | 556-02-5 | |
| 分子式 = 分子量 | C9H11NO3 = 181.1 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | From Chemical synthesis | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| D-酪胺酸 | CFN70141 | 556-02-5 | 10mg | QQ客服:3004468091 |
| D-酪胺酸 | CFN70141 | 556-02-5 | 20mg | QQ客服:3004468091 |
| D-酪胺酸 | CFN70141 | 556-02-5 | 50mg | QQ客服:3004468091 |
| D-酪胺酸 | CFN70141 | 556-02-5 | 100mg | QQ客服:3004468091 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity. It as a metabolic inhibitor of Bacillus subtilis.D-Tyrosine prevents hypertension in DOCA-saline treated uninephrectomised rats. | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.5218 mL | 27.6091 mL | 55.2181 mL | 110.4362 mL | 138.0453 mL |
| 5 mM | 1.1044 mL | 5.5218 mL | 11.0436 mL | 22.0872 mL | 27.6091 mL |
| 10 mM | 0.5522 mL | 2.7609 mL | 5.5218 mL | 11.0436 mL | 13.8045 mL |
| 50 mM | 0.1104 mL | 0.5522 mL | 1.1044 mL | 2.2087 mL | 2.7609 mL |
| 100 mM | 0.0552 mL | 0.2761 mL | 0.5522 mL | 1.1044 mL | 1.3805 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 表藤黄烯酸; Epigambogellic acid | CFN95438 | 1352191-85-5 | C38H44O8 = 628.8 | 5mg | QQ客服:3004468091 |
| 东莨菪碱; Scopolamine | CFN98200 | 51-34-3 | C17H21NO4 = 303.35 | 5mg | QQ客服:3004468091 |
| 伏立康唑; Voriconazole | CFN60411 | 137234-62-9 | C16H14F3N5O = 349.31 | 5mg | QQ客服:3004468088 |
| 箭藿苷A; Sagittatoside A | CFN90139 | 118525-35-2 | C33H40O15 = 676.67 | 5mg | QQ客服:3004468091 |